Humana Target Price

Where could HUM trade next? Consensus target price: $400.

Get informed when a big investor buys or sells

+ Follow

Share Price

$379.96

Average Target Price

$401.14

5.6% upside

21 analysts in the last 4 months

High: $513 | Low: $249

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-24	Wolfe ResearchJustin Lake	$450	18.4% upside
2026-08-04	Morgan Stanley	$370	2.6% downside
2026-07-31	Barclays	$407	7.1% upside
2026-07-30	OppenheimerMichael Wiederhorn	$405	6.6% upside
2026-07-30	Piper Sandler	$463	21.9% upside
2026-07-30	Robert W. Baird	$390	2.6% upside
2026-07-30	Guggenheim	$471	24% upside
2026-07-30	Leerink Partners	$513	35% upside
2026-07-30	UBS	$405	6.6% upside
2026-07-29	Evercore ISI	$480	26.3% upside
2026-07-20	Jefferies	$410	7.9% upside
2026-07-14	Truist FinancialDavid MacDonald	$415	9.2% upside
2026-07-13	Wells FargoStephen Baxter	$502	32.1% upside
2026-07-09	RBC Capital	$415	9.2% upside
2026-07-07	Raymond JamesSarah James	$300	21% downside
2026-07-07	Cantor Fitzgerald	$300	21% downside
2026-06-08	Mizuho Securities	$390	2.6% upside
2026-06-04	Morgan Stanley	$249	34.5% downside
2026-06-03	Bernstein	$425	11.9% upside
2026-06-01	Truist FinancialDavid MacDonald	$320	15.8% downside
2026-05-26	Barclays	$344	9.5% downside
2026-05-22	UBS	$320	15.8% downside
2026-05-20	Mizuho Securities	$335	11.8% downside
2026-05-20	Deutsche Bank	$441	16.1% upside
2026-05-15	Morgan StanleyErin Wright	$217	42.9% downside
2026-05-13	Piper Sandler	$254	33.2% downside
2026-05-01	Raymond James	$260	31.6% downside
2026-04-30	Truist FinancialDavid MacDonald	$270	28.9% downside
2026-04-30	Oppenheimer	$260	31.6% downside
2026-04-30	Deutsche Bank	$235	38.2% downside
2026-04-30	RBC CapitalBen Hendrix	$246	35.3% downside
2026-04-30	Guggenheim	$269	29.2% downside
2026-04-30	Barclays	$180	52.6% downside
2026-04-30	UBS	$262	31% downside
2026-04-08	Mizuho Securities	$258	32.1% downside
2026-04-08	Evercore ISI	$195	48.7% downside
2026-02-18	Wells Fargo	$206	45.8% downside
2026-02-17	Truist Financial	$200	47.4% downside
2026-02-13	Deutsche BankGeorge Hill	$180	52.6% downside
2026-02-12	Oppenheimer	$250	34.2% downside
2026-02-12	RBC CapitalBen Hendrix	$189	50.3% downside
2026-02-12	Raymond JamesSarah James	$201	47.1% downside
2026-02-12	Morgan Stanley	$146	61.6% downside
2026-02-12	UBS	$195	48.7% downside
2026-02-12	Guggenheim	$252	33.7% downside
2026-02-02	Morgan Stanley	$174	54.2% downside
2026-01-07	Wells Fargo	$290	23.7% downside
2026-01-06	Bernstein	$344	9.5% downside
2025-12-18	Morgan StanleyErin Wright	$262	31% downside
2025-12-05	JefferiesDavid Windley	$313	17.6% downside

Humana (HUM) FAQ

Humana (HUM) currently reports a target price of $400. Use the charts on this page to explore Humana's target price history and peer comparisons.

Analysts' average 12-month price target for Humana is $400, about 5.6% upside from the current share price of $379.96. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $400, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Humana, and consider following HUM for alerts when major investors trade the stock.

Humana is classified in the Healthcare sector. On target price, it currently shows $400. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HUM with unrelated industries.